Studies of animal models of NAFLD suggest that HIF2α activation in this disease context may drive increased lipogenesis, thus worsening lipid accumulation in the liver (see Figure 2). The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatotic liver disease.